Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Aggrastat
Tirofiban is an antiplatelet drug used to prevent blood clots. It belongs to a class of medications called glycoprotein IIb/IIIa inhibitors, which work by blocking the final step in platelet aggregation. This helps to reduce the risk of heart attack or stroke in patients with unstable angina or those undergoing percutaneous coronary intervention (PCI).
Tirofiban is used to prevent blood clots in patients with unstable angina or undergoing PCI.
Increased risk of bleeding, including major and fatal hemorrhagic events. Use with caution in patients at high risk of bleeding.
Outcome:
Increased bleeding risk
Mechanism:
Both drugs affect coagulation pathways.
Outcome:
Increased bleeding risk
Mechanism:
Additive antiplatelet effects.
Outcome:
Potentially increased bleeding risk
Mechanism:
SSRIs may affect platelet function.
Most likely new formulation: Extended-release formulation (2025, 30% confidence)
Based on current usage trends and clinical trial data, there is a low likelihood of significant regulatory changes in the next 2 years.
Antiplatelet, Glycoprotein IIb/IIIa Inhibitor
Non-peptide Tyrosine Derivative